📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
JAGSONPAL PHARMACEUTICALS LIMITEDJAGSNPHARMPharmaceuticals
Open
169.99
High
173.12
Low
162.05
Close
163.73
Volume
120353
Exchange
nse
Time
23-Jan-2026

Outlook

Score:

0.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofJagsonpalPharmaceuticalsis
Long Body
EstimatedStoplossofJagsonpalPharmaceuticalsis
173.12
JagsonpalPharmaceuticalshasa
Bearishℹ
pattern.
Formationof
Long Body
candlepatternindicatesJagsonpalPharmaceuticalshaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

JagsonpalPharmaceuticalsisin
Downtrendℹ
.
PriceofJagsonpalPharmaceuticalsis
Downℹ
by

14.81

%.
Target
Buy@

155

Sell@

217.7

Current@

163.73

Volume

ThetradesofJagsonpalPharmaceuticalshavebeenin
Immenseℹ
volume.
ThevolumetradesforJagsonpalPharmaceuticalsare
Bearishℹ
with
Strong Sellersℹ
ThetradevolumeofJagsonpalPharmaceuticalsis

Up

by

114.77

%

Valuation

ThecurrentmarketpriceofJagsonpalPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth278crandtotalassetsworth278cr,thebalancesheetofJagsonpalPharmaceuticalsis:
Balancedℹ
.
Cashflow
JagsonpalPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 1cr

.Itis
Downℹ
by

200

%.
49.55% i.e. ₹ 55cr earned in operatingℹ
40.54% i.e. ₹ 45cr spent in investingℹ
9.91% i.e. ₹ 11cr spent in financingℹ
0% in otherℹ
JagsonpalPharmaceuticalshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 1cr

.Itis
Upℹ
by

109.09

%.
52.24% i.e. ₹ 35cr earned in operatingℹ
35.82% i.e. ₹ 24cr spent in investingℹ
11.94% i.e. ₹ 8cr spent in financingℹ
0% in otherℹ
Income
TheincomeofJagsonpalPharmaceuticalsis

₹ 77cr

and

Profit

is:

₹ 12cr

JagsonpalPharmaceuticalsProfitisupby:

20

%andIncomeisDownby:

1.28

%
TheincomeofJagsonpalPharmaceuticalsis

₹ 78cr

and

Profit

is:

₹ 10cr

JagsonpalPharmaceuticalsProfitisupby:

66.67

%andIncomeisUpby:

27.87

%
TheincomeofJagsonpalPharmaceuticalsis

₹ 61cr

and

Profit

is:

₹ 6cr

JagsonpalPharmaceuticalsProfitisdownby:

80.65

%andIncomeisDownby:

19.74

%
By using this site you agree to the use of cookies to deliver a better site experience.